Ameriprise’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-37,767
Closed -$60K 3807
2019
Q4
$60K Buy
37,767
+22,167
+142% +$62K ﹤0.01% 3667
2019
Q3
$62K Buy
+15,600
New +$90.7K ﹤0.01% 3658
2017
Q3
Sell
-15,540
Closed -$755K 3800
2017
Q2
$755K Sell
15,540
-9,067
-37% -$534K ﹤0.01% 3071
2017
Q1
$1.78M Buy
24,607
+2,349
+11% +$155K ﹤0.01% 2629
2016
Q4
$1.27M Sell
22,258
-85,735
-79% -$7.85M ﹤0.01% 2852
2016
Q3
$13.8M Sell
107,993
-7,641
-7% -$978K 0.01% 1195
2016
Q2
$14.4M Buy
115,634
+94,456
+446% +$10.9M 0.01% 1119
2016
Q1
$1.77M Buy
21,178
+2,248
+12% +$185K ﹤0.01% 2581
2015
Q4
$1.87M Buy
18,930
+1,404
+8% +$151K ﹤0.01% 2642
2015
Q3
$2.15M Buy
17,526
+55
+0.3% +$7.47K ﹤0.01% 2574
2015
Q2
$2.68M Buy
17,471
+103
+0.6% +$17K ﹤0.01% 2564
2015
Q1
$2.96M Sell
17,368
-6,372
-27% -$965K ﹤0.01% 2389
2014
Q4
$3.63M Sell
23,740
-3,101
-12% -$387K ﹤0.01% 2247
2014
Q3
$2.85M Sell
26,841
-2,276
-8% -$317K ﹤0.01% 2350
2014
Q2
$4.43M Sell
29,117
-1,237
-4% -$165K ﹤0.01% 2153
2014
Q1
$3.91M Sell
30,354
-18,491
-38% -$2.88M ﹤0.01% 2181
2013
Q4
$8.52M Buy
48,845
+4,583
+10% +$787K 0.01% 1611
2013
Q3
$7.14M Sell
44,262
-45,762
-51% -$7.21M ﹤0.01% 1695
2013
Q2
$12M Buy
+90,024
New +$12.7M 0.01% 1310

Other funds holding ELGX

Ameriprise's ELGX Position: Q1 2020 in Review

Ameriprise sold out of Endologix Inc (ELGX) in Q1 2020, closing a stake of 37,767 shares — an estimated $60K sold.

Ameriprise first reported a position in ELGX in Q2 2013 and held it in 19 quarters. The position peaked at $14.4M in Q2 2016. 50 funds tracked by Wall St. Rank hold ELGX as of Q1 2020.

  • Ameriprise reported no remaining Endologix Inc position as of Q1 2020 after selling out during the quarter.
  • Ameriprise sold 37,767 Endologix Inc shares in Q1 2020, an estimated $60K.
  • Ameriprise first reported a position in Endologix Inc in Q2 2013 and held it in 19 quarters.
  • Ameriprise's Endologix Inc position peaked at $14.4M in Q2 2016.
  • 50 funds tracked by Wall St. Rank held Endologix Inc as of Q1 2020.

Based on Ameriprise's 13F filing for Q1 2020, filed 15 May 2020.